Picture of NovoCure logo

NVCR — NovoCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

NovoCure Limited reports results for the quarter ended September 30 - Earnings Summary

NovoCure Limited reports results for the quarter ended September 30 - Earnings Summary
  • NovoCure Limited NVCR.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -33 cents. The mean expectation of seven analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -32 cents to -14 cents per share.

  • Revenue rose 15.7% to $193.40 million from a year ago; analysts expected $182.23 million.

  • NovoCure Limited's reported EPS for the quarter was a loss of 9 cents​.

  • The company reported a quarterly loss of $10.44 million.

  • NovoCure Limited shares had fallen by 11.2% this quarter and gained 9.6% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts was unchanged in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

  • Wall Street's median 12-month price target for NovoCure Limited is $23.50, about 39.7% above its last closing price of $14.17

This summary was machine generated from LSEG data October 29 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

-0.24

-0.09

Beat

Jun. 30 2026

-0.33

-0.17

Beat

Mar. 31 2026

-0.51

-0.62

Missed

Dec. 31 2025

-0.41

-0.22

Beat

Recent news on NovoCure

See all news